Loading company
Legend Biotech Corp
LEGN · Nasdaq · ·
Next earnings: November 11, 2026
$18.81+1.0%Sep 29 close
- 1M
- -11.0%
- 6M
- -1.3%
- 1Y
- -42.4%
- 5Y
- -60.0%
LEGN · Nasdaq · ·
Next earnings: November 11, 2026
$18.81+1.0%Sep 29 close
Legend Biotech Corp is scheduled to report next on November 11, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending March 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2026 | 3 months toMar 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $305.1M | $195M | +56.46% |
| Profit | -$54.3M | -$54.3M | 0.00% |
| Profit per share | -$0.18 | $0.16 | -212.50% |
| Free Cash Flow | -$24.6M | -$84.4M | +70.89% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
The quote and the company description come from the 6-K Legend Biotech Corp filed on August 11, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Legend Biotech Corp has no earnings call transcript available.